March 2026 - Defense time!

Congratulations! Max Schaaf successfully defended his PhD thesis. His research focused on the development of surface-functionalized, drug-loaded liposomes for targeted activation of immune cells. By combining polymer-based design with advanced characterization, he achieved high in vivo targeting specificity (e.g., cDC1 dendritic cells) and stable encapsulation of poorly soluble drugs like diABZI. His work bridges polymer science, nanomedicine, and immunology — paving the way for next-generation precision therapies.